Dana-Farber researchers present findings in more than 70 research studies at ASCO

Boston – Dana-Farber Cancer Institute researchers are presenting more than 70 research studies at the 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31st- June 4th. ASCO is the world’s largest clinical cancer research meeting, attracting more than 30,000 oncology professionals from around the world. The latest cancer research…

SIOP star shines brightly

IMAGE: Official logo for the Society for Industrial and Organizational Psychology view more  Credit: SIOP Michele J. Gelfand, Distinguished University Professor in the Department of Psychology at University of Maryland, is part of an illustrious group including Former First Lady Michelle Obama and more than 200 other luminaries elected to the American Academy of Arts and…

2 catheters originally developed by Dr. Riyaz Bashir receive premarket clearance by FDA

Credit: Thrombolex, Inc. (Philadelphia, PA) – The U.S. Food and Drug Administration (FDA) has granted premarket notification clearance for two catheters invented by Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of Vascular and Endovascular Medicine at Temple University Hospital, and Nicholas…

IU researchers develop electric field-based dressing to help heal wound infections

IMAGE: Chandan Sen, PhD view more  Credit: Indiana University School of Medicine Researchers at Indiana University School of Medicine have found a way to charge up the fight against bacterial infections using electricity. Work conducted in the laboratories of the Indiana Center for Regenerative Medicine and Engineering, Chandan Sen, PhD and Sashwati Roy, PhD has led…

Clinical trial at IU School of Medicine improves treatment of genetic rickets

IMAGE: Erik Imel, MD view more  Credit: Indiana University School of Medicine A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. The findings are published in Lancet. X-linked hypophosphatemia, or XLH, is a…